Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Minority Interest (2020 - 2022)

Historic Minority Interest for Bio-Techne (TECH) over the last 3 years, with Q2 2022 value amounting to -$759000.0.

  • Bio-Techne's Minority Interest fell 10918.55% to -$759000.0 in Q2 2022 from the same period last year, while for Jun 2022 it was -$759000.0, marking a year-over-year decrease of 10918.55%. This contributed to the annual value of -$759000.0 for FY2022, which is 10918.55% down from last year.
  • Bio-Techne's Minority Interest amounted to -$759000.0 in Q2 2022, which was down 10918.55% from -$1.1 million recorded in Q1 2022.
  • In the past 5 years, Bio-Techne's Minority Interest registered a high of $8.9 million during Q4 2020, and its lowest value of -$1.1 million during Q1 2022.
  • Its 3-year average for Minority Interest is $4.4 million, with a median of $7.6 million in 2021.
  • As far as peak fluctuations go, Bio-Techne's Minority Interest tumbled by 10512.42% in 2021, and later tumbled by 11241.61% in 2022.
  • Bio-Techne's Minority Interest (Quarter) stood at $8.9 million in 2020, then tumbled by 105.12% to -$458000.0 in 2021, then crashed by 65.72% to -$759000.0 in 2022.
  • Its last three reported values are -$759000.0 in Q2 2022, -$1.1 million for Q1 2022, and -$458000.0 during Q4 2021.